C07D 401/04
Directly linked by a ring-member-to-ring-member bond
Official title: directly linked by a ring-member-to-ring-member bond
C07D401/04 (Directly linked by a ring-member-to-ring-member bond) appears on 10,537 US grants and 12,258 published applications in this corpus.
Search patents in C07D- Granted patents
- 10,537
- Published applications
- 12,258
- Assignees
- 3,047
- Inventors
- 27,878
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 50 | 0 |
| 1977 | 24 | 0 |
| 1978 | 13 | 0 |
| 1979 | 4 | 0 |
| 1980 | 7 | 0 |
| 1981 | 14 | 0 |
| 1982 | 10 | 0 |
| 1983 | 11 | 0 |
| 1984 | 41 | 0 |
| 1985 | 60 | 0 |
| 1986 | 58 | 0 |
| 1987 | 71 | 0 |
| 1988 | 86 | 0 |
| 1989 | 116 | 0 |
| 1990 | 82 | 0 |
| 1991 | 103 | 0 |
| 1992 | 79 | 0 |
| 1993 | 105 | 0 |
| 1994 | 95 | 0 |
| 1995 | 112 | 0 |
| 1996 | 150 | 0 |
| 1997 | 202 | 0 |
| 1998 | 145 | 0 |
| 1999 | 151 | 0 |
| 2000 | 157 | 0 |
| 2001 | 145 | 28 |
| 2002 | 233 | 178 |
| 2003 | 188 | 312 |
| 2004 | 152 | 440 |
| 2005 | 190 | 485 |
| 2006 | 217 | 437 |
| 2007 | 247 | 443 |
| 2008 | 222 | 464 |
| 2009 | 288 | 494 |
| 2010 | 354 | 529 |
| 2011 | 325 | 510 |
| 2012 | 394 | 456 |
| 2013 | 417 | 493 |
| 2014 | 461 | 548 |
| 2015 | 506 | 617 |
| 2016 | 464 | 578 |
| 2017 | 535 | 592 |
| 2018 | 466 | 586 |
| 2019 | 449 | 560 |
| 2020 | 462 | 572 |
| 2021 | 380 | 524 |
| 2022 | 342 | 528 |
| 2023 | 287 | 593 |
| 2024 | 341 | 495 |
| 2025 | 322 | 467 |
| 2026 | 204 | 329 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Compositions and methods for parasite control6 Oct 2026US 12,751,453 B2Philip Morris Products S. A.
- PHD inhibitor compounds, compositions, and use6 Oct 2026US 12,753,161 B2Akebia Therapeutics, Inc.
- Method for producing 2-heteroarylpyridine compound6 Oct 2026US 12,753,162 B2Nippon Soda Co., Ltd.
- NAMPT modulators29 Sep 2026US 12,747,203 B2Cytokinetics, Inc.
- Membrane-active anti-bacterial compounds and uses thereof29 Sep 2026US 12,747,213 B2Regents of the University of Minnesota
- Triazole compound, and preparation method therefor, herbicidal composition and use thereof8 Oct 2026US 2026/0305610 A1Qingdao Kingagroot Chemical Compound Co., Ltd.
- Anti-inflammatory compounds, pharmaceutical compositions, and methods of treating hemochromatosis and other disorders8 Oct 2026US 2026/0306470 A1Miralogx LLC
- Estrogen-receptor modulator and use thereof8 Oct 2026US 2026/0308139 A1Jiangsu Vcare PharmaTech Co., Ltd.
- Cis-8-(3,5-Difluorophenyl)-8-(dimethylamino)-1,3-diazaspiro[4.5]decan-2-one derivatives8 Oct 2026US 2026/0308140 A1Gruenenthal GmbH
- Synthesis of orellanine8 Oct 2026US 2026/0308141 A1Oncorena AB
Most cited
By later US patents
- Pyrimidine derivatives and processes for the preparation thereof595US 5,521,184 ACiba-Geigy Corporation · 1996
- Method of reducing TNF.alpha. levels with amino substituted 2-(2,6-dioxopiperidin-3-yl)-1-oxo-and 1,3-dioxoisoindolines288US 5,635,517 ACelgene Corporation · 1997
- Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase226US 5,480,883 ARhone-Poulenc Rorer Pharmaceuticals Inc. · 1996
- 1,2-aryl and heteroaryl substituted imidazolyl compounds for the treatment of inflammation222US 5,616,601 AG. D. Searle & Co. · 1997
- Nitrogen containing heteroaromatics as factor Xa inhibitors211US 6,020,357 ADuPont Pharmaceuticals Company · 2000